Chief Financial Officer

• Sep 2022 - Present

I am part of the Active Directions network team focusing on Finance, Strategy, ERP (financials) & Operations Management. Active Directions is a flexible consulting practice delivering strategy, operational improvement, and exit and succession readiness services to the mid-market. We partner with like-minded accounting, investment and advisory firms to provide high quality management consulting services to their clients. Our team is made up of a diverse group of consultants and staff who enjoy project-based work as well as being part of a team. We bring consulting and management experience to our varied client and partner network. Show less

Chair - Finance, Audit & Risk Committee

• Jun 2022 - Present

The Australian Society of Orthodontists “ASO” helps patients understand their options for orthodontic treatment and provides information about dealing with the most qualified practitioners providing orthodontic care. The ASO provides factual information about orthodontic treatment. We rely on the best practice university and hospital research to ensure every time we are acting in the best interests of patient care. We have no financial interest in any orthodontic companies or techniques. The Australian Society of Orthodontists “ASO” helps patients understand their options for orthodontic treatment and provides information about dealing with the most qualified practitioners providing orthodontic care. The ASO provides factual information about orthodontic treatment. We rely on the best practice university and hospital research to ensure every time we are acting in the best interests of patient care. We have no financial interest in any orthodontic companies or techniques.

Chief Commercial Officer

• Sep 2021 - Sep 2022

Rapid Response Revival Research Limited is a medical technology development company focused on transforming the automated external defibrillator (AED) market. Our priority is the development of innovative AED solutions that make portable defibrillation affordable, accessible and effective for use by bystanders in the event of an out-of-hospital cardiac arrest (OHCA), with limited medical or first aid experience. With strict adherence to quality and medical device certification processes, along with valuable partnerships, we aim to bring improved, effective AED technology to the world, contributing to the solution of a worldwide health issue. Show less

Chief Financial Officer

• Feb 2020 - Aug 2021

BKH Group is NSW largest private structural construction company focusing on concrete and formwork developing some of NSW largest landmark and iconic infrastructure projects including: the new Sydney Football Stadium and various complex Metro Stations and oversite development towers in Sydney. BKH Group is NSW largest private structural construction company focusing on concrete and formwork developing some of NSW largest landmark and iconic infrastructure projects including: the new Sydney Football Stadium and various complex Metro Stations and oversite development towers in Sydney.

Chief Financial Officer

• Oct 2015 - Nov 2019

OncoSil Medical is an ASX company developing nuclear medicine radiation treatments based on its proprietary technology platform. The lead product in development is OncoSil™, a class III medical device which can be implanted directly into tumours to create a local radiation field that maximizes tumour exposure to radiation. The role was the business lead and partner to the CEO in the project management and delivery of the >$80M lead product budget, establishing protocols for development and plans commercialisation and market entry. Key achievements included: negotiating agreements with major US/UK & Australian hospitals relating to the clinical trial program; production efficiency leading to >50% gross margin savings; successfully raised >$35.0M to further development program and the development and implementation of a change and restructure program. Show less

CEO

• May 2012 - Oct 2015

Allegra Orthopeadics Limited is an ASX listed integrated orthopaedic medical device sales organisation – local manufacturing, design and regulatory capabilities.During a time when the founder moved on the Board turned to me to lead the organisation as the CEO. The key aspects of the role was the development of relationships with surgeon customers, hospital groups, government bodies and departments to establish trust and awareness of an Australian manufacturer. Key achievements included: Organisational cultural change and business transformation through leadership, values, vision and lean initiatives; developing local innovation from concept to completion including regulatory and reimbursement pathways; negotiating transactions with large US orthopaedic companies including sale and acquisition of technology/rights; leading & negotiating contracts with local research institutions for technology transfers and the successful NSW Medical Device Fund grant $1.6m. Show less

Chief Financial Officer

• Sep 2007 - May 2012

The role was the financial lead on the IPO and delivering financial and business leadership across sales, manufacturing, quality, design, customer service and finance teams. Key achievements included; development and management of an effective R&D strategy to maximise financial returns and project benefits; introducing R&D performance metrics, roll out of new Enterprise system and identification and delivery of cost saving opportunities via "Lean"education and training .

Chief Financial Officer - Residential Land Partners

• Mar 2006 - Sep 2007

Babcock & Brown Residential Land Partners was an ASX listed Finance and Property Company developing a broad group circa $300M residential land and development assets/projects across Australian and New Zealand. The role was the financial lead on the establishment of the listed fund through the aggregation of various assets and contractual interests, the merger of these assets into a stapled security and IPO raising $175M. In addition, establishing the reporting framework both operational and for statutory purposes, lending facilities both corporate and project based and establishing the process for strategic plans, budgets, quarterly forecasts and portfolio reviews. Key achievements included; IPO $175M close, translation of complex legal agreements into accounting transactions; strong project management processes; establishing a robust and effective financial reporting and analysis structure in SAP and developing a strong relationship with partners. Show less

Chief Financial Officer & Company Secretary

• Apr 2004 - Dec 2005

Avantogen Oncology Inc, was ASX listed biotechnology company developing a broad oncology-related product portfolio which was previously based in Sydney but was redomiciled to the USA. The role was responsible for project management the financial requirements of numerous oncology related trials and the reporting obligations for the group with the additional Company Secretary obligations. Key achievements included: financial lead on numerous capital raising transactions; preparation of NASDAQ registration documents; establishing a base on the West Coast of the USA and settlement of business acquisitions in the USA and Germany. Show less

Group Chief Accountant

• May 2000 - Apr 2004

The role was responsible for leading the Sydney Head Office Cochlear Limited Finance function (10 staff), group FP&A reporting function and statutory reporting obligations. Business partnering with CFO, Operations and other Global Head Office functions to deliver services as required to drive performance and indicators. Annual revenue >$300M with +20% YoY growth. Key achievements included restructured and standardised reporting to increase efficiency, accuracy and speed of delivery; successful project management of Oracle Financials & Procure to Pay and developing a deep understanding of manufacturing processes to identify opportunities to improve efficiencies. Show less

Group Accountant

• Apr 1996 - Apr 2000